title: Clones of tumor cells derived from a single primary human lung tumor reveal different patterns of beta 1 integrin expression.
abstract: Previously we reported that over 75% of human non-small cell lung cancers overexpress the beta 1 integrin VLA-2 on their surface and show an increase in the mRNA encoding the alpha-2 chain of this integrin. These results suggested the possibility that the overproduction and overexpression of one or more of the beta 1 integrin may be involved in the pathogenesis of human lung tumors by modulating the invasive and/or metastatic potential of the tumor. We report here the generation and characterization of multiple clones of tumor cells derived from the primary culture of cells obtained from biopsy tissue of an aggressive human squamous cell lung tumor. We show that these tumor clones (or clonotypes) exhibit seven different yet stable phenotypes with respect to the expression of five members of the beta 1 integrin family. These results illustrate that a primary human lung tumor consists of multiple subpopulations of cells that while indistinguishable by ultrastructure are heterogeneous with respect to their beta 1 integrins. The availability of these distinct tumor clonotypes derived from a single tumor biopsy have made it possible to test the assumption that the beta 1 integrins play a role in tumor progression. The feasibility of this approach is demonstrated here by the intravenous inoculation of different human tumor clonotypes into severe combined immunodeficient (scid) mice. Our preliminary results with a pair of tumor clonotypes differing in VLA-1 and VLA-2 expression level reveal that the clonotype with high level of VLA-1 and VLA-2 displays a substantial increase in the experimental engraftment and metastasis of the human tumor cells in scid mice.
authors.affiliation: Department of Molecular Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263.
authors.forename: F A
authors.initials: FA
authors.lastname: Chen
authors.forename: T
authors.initials: T
authors.lastname: Alosco
authors.forename: B A
authors.initials: BA
authors.lastname: Croy
authors.forename: K
authors.initials: K
authors.lastname: Narumi
authors.forename: D H
authors.initials: DH
authors.lastname: Percy
authors.forename: R B
authors.initials: RB
authors.lastname: Bankert
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000556:secondary; D002352:Carrier Proteins / Q000032:analysis; D002448:Cell Adhesion; D002999:Clone Cells; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D006801:Humans; D018960:Hyaluronan Receptors; D019012:Integrin beta1; D016023:Integrins / Q000032:analysis*; D008175:Lung Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000556:secondary; D051379:Mice; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D011956:Receptors, Cell Surface / Q000032:analysis; D016201:Receptors, Lymphocyte Homing / Q000032:analysis; D016029:Receptors, Very Late Antigen / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D002352:Carrier Proteins; D016326:Extracellular Matrix Proteins; D018960:Hyaluronan Receptors; D019012:Integrin beta1; D016023:Integrins; D011956:Receptors, Cell Surface; D016201:Receptors, Lymphocyte Homing; D016029:Receptors, Very Late Antigen